Gender differences in the development of experimental liver steatosis in laboratory rats

Author:

Bulatova I. A.1,Shevlyukova T. P.2,Gulyaeva I. L.1

Affiliation:

1. Perm State Medical University n.a E. A. Wagner of the Ministry of Health of the Russian Federation

2. Tyumen State Medical University of the Ministry of Health of the Russian Federation

Abstract

The aim. To study functional-morphological and biometric changes in the liver and lipid spectrum in an experiment in male and female laboratory rats when modeling fructose-induced liver steatosis. Materials and methods. The experimental study was conducted on 44 non-inbred sexually mature white rats, of which 20 were males aged 8-9 months with a body weight of 400-530 g. and 24 females aged 9-10 months with a body weight of 320-480 g. Modeling of liver steatosis was carried out for 28 days by adding fructose to drinking water throughout the experiment using 15%-th solution of fructose instead of drinking water. At the end of the experiment, body weight was measured, liver sampling for morphometric and histological studies and blood sampling for laboratory studies (transaminase, glucose and lipid spectrum levels) were performed. Results. When comparing body weight before the experiment and after its completion, a statistically significant increase in this indicator was found in females with experimental steatosis (p = 0.031), which indicates the formation of general obesity in them. The mass coefficient of the liver in the experimental groups of males and females with steatosis was significantly higher than in the controls (p= 0.009 and p = 0.009, respectively). During histological examination of liver tissue, the number of hepatocytes with steatosis in males and females in experimental models was significantly higher than in control groups and corresponded to the II-III degree of steatosis. A comparative analysis of the lipidogram parameters revealed that dyslipidemia developed during the formation of liver steatosis in animals of both groups with fructose-induced liver steatosis. Conclusion. In experimental modeling of fructose-induced liver steatosis in animals, regardless of gender, morphological changes in liver tissue are manifested by fatty dystrophy and hepatomegaly, dyslipidemia is registered. At the same time, males develop fermentemia, hyperglycemia without the formation of general obesity. In females, the course of experimental steatosis is accompanied by an increase in body weight without functional changes in the liver.

Publisher

LLC Global Media Technology

Subject

Gastroenterology,Hepatology

Reference19 articles.

1. Ivashkin V.T., Mayevskaya M. V., Pavlov Ch.S. et al. Clinical guidelines for the diagnosis and treatment of non-alcoholic fatty liver disease of the Russian Society for the Study of the Liver and the Russian Gastroenterological Association.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016; 2: 24-42. (in Russ.)@@ Ivashkin V. T., Maevskaya M. V., Pavlov Ch. S. i soavt. Klinicheskie rekomendatsii po diagnostike i lecheniyu nealkogol'noi zhirovoi bolezni pecheni Rossiiskogo obshchestva po izucheniyu pecheni i Rossiiskoi gastroenterologicheskoi assotsiatsii. Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2016; 2: 24-42.

2. Lazebnik L. B., Golovanova U. V., Turkina S. V. Non-alcoholic fatty liver disease in adults: clinic, diagnosis, treatment. Recommendations for therapists, the third version. Experimental and clinical gastroenterology. 2021; 185(1): 4-52. (in Russ.) doi: 10.31146/1682-8658-ecg-185-1-4-52.@@ Lazebnik L. B., Golovanova U. V., Turkina S. V. Nealkogol'naya zhirovaya bolezn' pecheni u vzroslykh: klinika, diagnostika, lechenie. Rekomendatsii dlya terapevtov, tret'ya versiya. Eksperimental'naya i klinicheskaya gastroenterologiya. 2021; 185(1): 4-52. doi: 10.31146/1682-8658-ecg-185-1-4-52.

3. Vinnitskaya E. V., Sandler Yu.G., Bordin D. S. A new paradigm of non-alcoholic fatty liver disease: phenotypic diversity of metabolically associated fatty liver disease. Effective pharmacotherapy. 2020; 16 (24): 54-63. (in Russ.) doi: 10.33978/2307-3586-2020-16-24-54-63.@@ Vinnitskaya E. V., Sandler Yu. G., Bordin D. S. Novaya paradigma nealkogol'noi zhirovoi bolezni pecheni: fenotipicheskoe mnogoobrazie metabolicheski assotsiirovannoi zhirovoi bolezni pecheni. Effektivnaya farmakoterapiya. 2020; 16 (24): 54-63. doi: 10.33978/2307-3586-2020-16-24-54-63.

4. Rotonya M. C., Amanke O., Vandana K. Non-alcoholic fatty liver disease: Pathophysiology and management. MScGastroenterol Clin North Am. 2016; 45 (4):639-652. doi: 10.1016/j.gtc.2016.07.003.

5. Florentino G.S. de A., Cotrim N. R., Vilar S. R. et al. Nonalcoholic fatty liver disease in menopausal women. Arq Gastroenterol. 2013; 50(3):180-185. doi: 10.1590/S0004-28032013000200032.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3